NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

Shares outstanding per last 10-Q: 562.5m

Offering: 11.8m
debt conv: 3.6m
Consulting: .6m

That's 578.5m for shares outstanding plus subsequent events through August 1st, so that agrees with your number.

470m potentially dilutive per last 10-Q, includes 350m warrants.

8.7m shares short per last FINRA data (9/13), which I note is about $2.1m at the latest share price.

My thoughts on short position:

$2.1m is not a great deal of money on the short side.

You could also look at short interest as a percent of shares out. Less than 2% is not a lot.

You could also look at days to cover. FINRA reports this as 1.5 days. That was after a very active 2 weeks of trading. Using a longer time period, the number is higher, but not unusual.

I agree that speculative shorting at $0.24 doesn't make a lot of sense, especially given the difficulty and cost of borrowing a low priced stock.

There isn't typically a lot of short interest in OTC stocks, largely because of the cost/difficulty of borrow already noted.

I agree with your thought that most of the short interst is likely to be hedged by warrants or convertibles.

I don't believe the Larry Smith "naked short" premise at all.

Hope that helps.